RA Capital Management »

Protara Therapeutic shares owned by RA Capital Management

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 1.9M 1.83
2024-06-30 $4.0M 1.9M 2.08

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH
Climb Bio SH (ELYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Protara Therapeutic

RA Capital Management
Opaleye Management
Stempoint Capital
Woodline Partners
Boxer Capital
Citadel Advisors
Baker Bros. Advisors
Armistice Capital
Vanguard Group
Renaissance Technologies
CVI Holdings
Oppenheimer & Co
Geode Capital Management
Two Sigma Investments
Ikarian Capital

View all funds holding Protara Therapeutic